Anne Marie Dingemans News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Anne marie dingemans. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Anne Marie Dingemans Today - Breaking & Trending Today

Promising New Therapy for Pulmonary Neuroendocrine Tumors

Promising New Therapy for Pulmonary Neuroendocrine Tumors
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Nielsfm Kok , Sylvie Lantuejoul Sridevi Jaksani , Lodewijkaa Brosens , Antonellafm Dost , Anne Marie Dingemans , Margot Tesselaar , Catherine Voegele , Talya Dayton , Nicolas Alcala , Wenzelm Hackeng , Koenj Hartemink , Lisa Hillen , Houkem Klomp , Harry Begthel , Sonja Levi , Kris Samsom , Gerlofd Valk , Wieneke Buikhuisen , Lise Mangiante , Talyal Dayton , Veerle Geurts , Jules Derks , Laura Moonen , Joep Beumer , Lynnette Fern , Alexandra Sexton Oates ,

First Patients Tested with InVisionFirst®-Lung in EORTC Sponsored Phase II NSCLC Study

First Patients Tested with InVisionFirst®-Lung in EORTC Sponsored Phase II NSCLC Study

First Patients Tested with InVisionFirst®-Lung in EORTC Sponsored Phase II NSCLC Study
Inivata’s InVisionFirst®-Lung is being used for ctDNA testing and monitoring of patients treated with lorlatinib
Study
supported by a grant from Pfizer Inc.
Research Triangle Park, NC, USA and Cambridge, UK, 20 January 2021 – Inivata, a leader in liquid biopsy, today announces that the first patients have been tested using InVisionFirst®-Lung as part of the Phase II ALKALINE trial sponsored by the European Organisation for Research and Treatment of Cancer (EORTC). As part of the study Inivata’s InVisionFirst-Lung liquid biopsy will be used to test and monitor ALK positive non-small cell lung cancer (NSCLC) patients initiating treatment with lorlatinib, Pfizer Inc.’s third generation ALK inhibitor therapy. ....

United States , United Kingdom , Comunidad Autonoma De Cataluna , Laura Mezquita , Clive Morris , Inivata Invisionfirst , Anne Marie Dingemans , Karen Chandler Smith , Usinginivata Invisionfirst , Treatment Of Cancer European Organisation For Research , Cancer Research United Kingdom Cambridge Institute , Erasmus University Medical Center , European Organisation For Research , University Of Cambridge , Department Of Medical Oncology , Erasmus Mc Cancer Institute , Pfizer Inc , Research Triangle Park , Patients Tested , Triangle Park , European Organisation , Chief Executive Officer , Medical Oncology , Hospital Clinic , Consilium Strategic Communications Chris , Sarah Wilson ,